Cargando…

Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic

The COVID pandemic has transformed our approach to patient care, research, and training in cardio-oncology. While the early phases of the COVID pandemic were exceptionally frightening, we now can reflect on the innovative changes that brought more effective and patient-centered care to our doorsteps...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondapalli, Lavanya, Arora, Garima, Hawi, Riem, Andrikopoulou, Efstathia, Estes, Courtney, Patel, Nirav, Lenneman, Carrie G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376567/
https://www.ncbi.nlm.nih.gov/pubmed/35969312
http://dx.doi.org/10.1007/s11864-022-00997-7
_version_ 1784768172679757824
author Kondapalli, Lavanya
Arora, Garima
Hawi, Riem
Andrikopoulou, Efstathia
Estes, Courtney
Patel, Nirav
Lenneman, Carrie G.
author_facet Kondapalli, Lavanya
Arora, Garima
Hawi, Riem
Andrikopoulou, Efstathia
Estes, Courtney
Patel, Nirav
Lenneman, Carrie G.
author_sort Kondapalli, Lavanya
collection PubMed
description The COVID pandemic has transformed our approach to patient care, research, and training in cardio-oncology. While the early phases of the COVID pandemic were exceptionally frightening, we now can reflect on the innovative changes that brought more effective and patient-centered care to our doorsteps: expansion of telemedicine, integration of digital health, wider adoption of cardiac biomarkers, consolidation, and coordination of cardio-oncology testing. Normally, it takes years for health care systems to adopt new technology or modify patient care pathways; however, COVID pushed healthcare providers and the health systems to change at warp speed. All of these innovations have improved our efficacy and provided a more “patient-centered” approach for our cardio-oncology patients. The changes we have made in cardio-oncology will likely remain well beyond the pandemic and continue to grow improving the cardiovascular care of oncology patients.
format Online
Article
Text
id pubmed-9376567
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-93765672022-08-15 Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic Kondapalli, Lavanya Arora, Garima Hawi, Riem Andrikopoulou, Efstathia Estes, Courtney Patel, Nirav Lenneman, Carrie G. Curr Treat Options Oncol Cardio-oncology (MG Fradley, Section Editor) The COVID pandemic has transformed our approach to patient care, research, and training in cardio-oncology. While the early phases of the COVID pandemic were exceptionally frightening, we now can reflect on the innovative changes that brought more effective and patient-centered care to our doorsteps: expansion of telemedicine, integration of digital health, wider adoption of cardiac biomarkers, consolidation, and coordination of cardio-oncology testing. Normally, it takes years for health care systems to adopt new technology or modify patient care pathways; however, COVID pushed healthcare providers and the health systems to change at warp speed. All of these innovations have improved our efficacy and provided a more “patient-centered” approach for our cardio-oncology patients. The changes we have made in cardio-oncology will likely remain well beyond the pandemic and continue to grow improving the cardiovascular care of oncology patients. Springer US 2022-08-15 2022 /pmc/articles/PMC9376567/ /pubmed/35969312 http://dx.doi.org/10.1007/s11864-022-00997-7 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Cardio-oncology (MG Fradley, Section Editor)
Kondapalli, Lavanya
Arora, Garima
Hawi, Riem
Andrikopoulou, Efstathia
Estes, Courtney
Patel, Nirav
Lenneman, Carrie G.
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
title Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
title_full Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
title_fullStr Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
title_full_unstemmed Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
title_short Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
title_sort innovations in cardio-oncology resulting from the covid-19 pandemic
topic Cardio-oncology (MG Fradley, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376567/
https://www.ncbi.nlm.nih.gov/pubmed/35969312
http://dx.doi.org/10.1007/s11864-022-00997-7
work_keys_str_mv AT kondapallilavanya innovationsincardiooncologyresultingfromthecovid19pandemic
AT aroragarima innovationsincardiooncologyresultingfromthecovid19pandemic
AT hawiriem innovationsincardiooncologyresultingfromthecovid19pandemic
AT andrikopoulouefstathia innovationsincardiooncologyresultingfromthecovid19pandemic
AT estescourtney innovationsincardiooncologyresultingfromthecovid19pandemic
AT patelnirav innovationsincardiooncologyresultingfromthecovid19pandemic
AT lennemancarrieg innovationsincardiooncologyresultingfromthecovid19pandemic